Check Out What Whales Are Doing With Morgan Stanley - Morgan Stanley (NYSE:MS)
Stay updated with breaking news from Benzinga Pro. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tuesday, the FDA approved Amgen Inc (NASDAQ:AMGN) Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to AstraZeneca Plc’s (NASDAQ:AZN) Soliris (eculizumab) to treat certain rare diseases. Bkemv is approved for the following treatment indications, which are also currently approved for Soliris: The treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH) to reduce hemolysis. The treatment of patients with atypical hemolytic uremic syndrome (aHUS) to inhibit complement-medi
Cue Health shares are trading lower by 27.5% during Wednesday's session. The company announced that it filed voluntary petitions under Chapter 7 of the U.S. Bankruptcy Code.
UiPath shares are trading lower on heavy volume Wednesday ahead of the company's first-quarter earnings report. Here's a look at what's going on.